These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2314410)
21. Flow cytometric characterization of normal and variant cells with monoclonal antibodies specific for glycophorin A. Langlois RG; Bigbee WL; Jensen RH J Immunol; 1985 Jun; 134(6):4009-17. PubMed ID: 3857280 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279 [TBL] [Abstract][Full Text] [Related]
23. Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma. Okada S; Ishii H; Nose H; Okusaka T; Kyogoku A; Yoshimori M; Wakabayashi K Carcinogenesis; 1997 Feb; 18(2):445-9. PubMed ID: 9054641 [TBL] [Abstract][Full Text] [Related]
24. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149 [TBL] [Abstract][Full Text] [Related]
25. Detection of mutagenic activity in human urine using mutant strains of Salmonella typhimurium. Minnich V; Smith ME; Thompson D; Kornfeld S Cancer; 1976 Sep; 38(3):1253-8. PubMed ID: 782687 [TBL] [Abstract][Full Text] [Related]
27. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102. Hutchins LF; Green SJ; Ravdin PM; Lew D; Martino S; Abeloff M; Lyss AP; Allred C; Rivkin SE; Osborne CK J Clin Oncol; 2005 Nov; 23(33):8313-21. PubMed ID: 16293862 [TBL] [Abstract][Full Text] [Related]
28. Effect of enzymes on the attachment of influenza and encephalomyocarditis viruses to erythrocytes. Burness AT; Pardoe IU J Gen Virol; 1981 Aug; 55(Pt 2):275-88. PubMed ID: 6270264 [TBL] [Abstract][Full Text] [Related]
29. Erythrocyte sialoglycoproteins and Plasmodium falciparum invasion. Facer CA Trans R Soc Trop Med Hyg; 1983; 77(4):524-30. PubMed ID: 6356506 [TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy in early breast cancer. Ejlertsen B Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018 [TBL] [Abstract][Full Text] [Related]
31. Expression of red cell membrane proteins in erythroid precursor cells. Yurchenco PD; Furthmayr H J Supramol Struct; 1980; 13(2):255-69. PubMed ID: 6941050 [TBL] [Abstract][Full Text] [Related]
32. Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Langlois RG; Bigbee WL; Jensen RH; German J Proc Natl Acad Sci U S A; 1989 Jan; 86(2):670-4. PubMed ID: 2911598 [TBL] [Abstract][Full Text] [Related]
33. Miltenberger Class I and II erythrocytes carry a variant of glycophorin A. Blanchard D; Asseraf A; Prigent MJ; Cartron JP Biochem J; 1983 Aug; 213(2):399-404. PubMed ID: 6615443 [TBL] [Abstract][Full Text] [Related]
34. 'Spontaneous' genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status. MacGregor JT; Wehr CM; Hiatt RA; Peters B; Tucker JD; Langlois RG; Jacob RA; Jensen RH; Yager JW; Shigenaga MK; Frei B; Eynon BP; Ames BN Mutat Res; 1997 Jun; 377(1):125-35. PubMed ID: 9219587 [TBL] [Abstract][Full Text] [Related]
35. Abnormal blood-group-Ss-active sialoglycoproteins in the membrane of Miltenberger class III, IV and V human erythrocytes. Anstee DJ; Mawby WJ; Tanner MJ Biochem J; 1979 Nov; 183(2):193-203. PubMed ID: 230820 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer. Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456 [TBL] [Abstract][Full Text] [Related]
37. The human red cell sialoglycoprotein, glycophorin A: biosynthesis, glycosylation and interaction with external ligands. Gahmberg CG; Hermonen J Indian J Biochem Biophys; 1988; 25(1-2):133-6. PubMed ID: 3053409 [No Abstract] [Full Text] [Related]
38. Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Jensen RH; Langlois RG; Bigbee WL; Grant SG; Moore D; Pilinskaya M; Vorobtsova I; Pleshanov P Radiat Res; 1995 Feb; 141(2):129-35. PubMed ID: 7838951 [TBL] [Abstract][Full Text] [Related]
39. Abnormal minor human erythrocyte membrane sialoglycoprotein (beta) in association with the rare blood-group antigen Webb (Wb). Reid ME; Shaw MA; Rowe G; Anstee DJ; Tanner MJ Biochem J; 1985 Nov; 232(1):289-91. PubMed ID: 4084234 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay. Grant SG; Reeger W; Wenger SL Genet Test; 1997-1998; 1(4):261-7. PubMed ID: 10464655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]